President Trump signed an executive order on Saturday calling for the acceleration of research on certain psychedelic drugs as treatments for depression and other conditions.

Donald Trump has signed an executive order seeking to hasten research into the therapeutic benefits of LSD, ecstasy, psilocybin and other mind-altering drugs by ordering United States federal agencies...

The president also announced that the federal government is making a $50 million investment for further research into the psychedelic drug ibogaine.